BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Staging
11 results:

  • 1. Utility of FDG PET/CT for Preoperative staging of Non-Small Cell lung cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller.
    Suh YJ; Park CM; Han K; Jeon SK; Kim H; Hwang EJ; Lee JH; Paeng JC; Lee CH; Kim YT; Goo JM
    AJR Am J Roentgenol; 2020 Mar; 214(3):514-523. PubMed ID: 31846374
    [No Abstract]    [Full Text] [Related]  

  • 2. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell lung cancer.
    Stokes SM; Massarweh NN; Stringham JR; Varghese TK
    Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Screening and staging for non-small cell lung cancer by serum laser Raman spectroscopy.
    Wang H; Zhang S; Wan L; Sun H; Tan J; Su Q
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Aug; 201():34-38. PubMed ID: 29729529
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. National cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell lung cancer.
    Higgins KA; O'Connell K; Liu Y; Gillespie TW; McDonald MW; Pillai RN; Patel KR; Patel PR; Robinson CG; Simone CB; Owonikoko TK; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):128-137. PubMed ID: 27979443
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Kavanaugh M; Wu XC
    BMC Cancer; 2016 Jul; 16():460. PubMed ID: 27412163
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of Endobronchial Ultrasound-Guided Fine Needle Aspiration and Video-Assisted Mediastinoscopy for Mediastinal staging of lung cancer.
    Ge X; Guan W; Han F; Guo X; Jin Z
    Lung; 2015 Oct; 193(5):757-66. PubMed ID: 26186887
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinicopathological significance and potential drug targeting of cdh1 in lung cancer: a meta-analysis and literature review.
    Yu Q; Guo Q; Chen L; Liu S
    Drug Des Devel Ther; 2015; 9():2171-8. PubMed ID: 25931811
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.
    Fernandez S; Risolino M; Mandia N; Talotta F; Soini Y; Incoronato M; Condorelli G; Banfi S; Verde P
    Oncogene; 2015 Jun; 34(25):3240-50. PubMed ID: 25151966
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. 18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: a systematic review and meta-analysis.
    Lu YY; Chen JH; Liang JA; Chu S; Lin WY; Kao CH
    Nucl Med Commun; 2014 Jul; 35(7):697-703. PubMed ID: 24694775
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
    Qi RX; Xu XY
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Are bone scintigraphy examinations requested in oncologic patients according to established indications?].
    Cortés Romera M; Talavera Rubio MP; García Vicente AM; Ruiz Solís S; Poblete García VM; Rodríguez Alfonso B; Palomar Muñoz A; Soriano Castrejón A
    Rev Esp Med Nucl; 2007; 26(5):286-93. PubMed ID: 17910837
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.